Nicotine policy, in perspective.

Independent reporting and analysis on nicotine policy and harm-reduction in Europe.

The latest developments

View all

Investigations

View all
A hand holds a printed disclosure stating that a report was commissioned by Sanofi and Regeneron.

Investigation · European Union ·

INVESTIGATION: Who’s behind the anti-nicotine propaganda?

Pharmaceutical companies selling costly treatments for smoking-related diseases also fund organisations campaigning for tighter restrictions on safer nicotine products. Peter examines whether those relationships deserve closer scrutiny.

Analysis & opinion

View all

Investigation · European Union ·

INVESTIGATION: Who’s behind the anti-nicotine propaganda?

Pharmaceutical companies selling costly treatments for smoking-related diseases also fund organisations campaigning for tighter restrictions on safer nicotine products. Peter examines whether those relationships deserve closer scrutiny.

Opinion · European Union ·

A European House Divided

While a TPD Revision Compromise Looks Impossible, Brussels is Walking into a Trust and Credibility Crisis

More from our reporting

View all

Science

View all

Stay ahead of policy.

Track proposals, consultations, decisions and the next confirmed dates.

Policy Track a country

Interviews

View all

Data

View all